title: Cutaneous Crohn's disease treated with infliximab and 4 years of follow up.
abstract: Metastatic Crohn's disease (MCD) is a rare, non-contiguous cutaneous manifestation of Crohn's disease. To date, there have been only four reports in the literature of an effective treatment of this condition with infliximab and there are no long-term follow-up studies on adult MCD patients treated with infliximab. We present a case of MCD treated with infliximab with 4.5 years of follow up.
authors.affiliation: Dermatology Department, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
authors.forename: Corinne
authors.initials: C
authors.lastname: Yoong
authors.forename: Clare
authors.initials: C
authors.lastname: Schofield
authors.forename: Karl
authors.initials: K
authors.lastname: Rodins
authors.forename: Catherine
authors.initials: C
authors.lastname: Faulkner
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology
chemical_list: D003879:Dermatologic Agents; D000069285:Infliximab
keywords: infliximab; metastatic Crohn's disease